Proposal of remission criteria for IgA nephropathy

Clinical and Experimental Nephrology

Volumn 18, Issue 3, 2014, Pages 481-486

  Suzuki, Yusuke ^a   Matsuzaki, Keiichi ^a   Suzuki, Hitoshi ^a   Sakamoto, Naoko ^b   Joh, Kensuke ^c   Kawamura, Tetsuya ^d   Tomino, Yasuhiko ^a   Matsuo, Seiichi ^e  

^a JUNTENDO UNIVERSITY   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c Sendai Shakaihoken Hospital   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NAGOYA UNIVERSITY   (Japan)

Author keywords

Hematuria; IgA nephropathy; Proteinuria; Remission criteria

Indexed keywords

ARTICLE; CLINICAL CLASSIFICATION; DISEASE DURATION; ERYTHROCYTE COUNT; HEALTH CARE SURVEY; HEMATURIA; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; JAPAN; NEPHROLOGIST; OCCULT BLOOD; PROTEINURIA; REMISSION; REMISSION CRITERIA; STANDARD; TEACHING HOSPITAL; URINALYSIS; URINARY SEDIMENT RED BLOOD CELL; URINE OCCULT BLOOD REACTION; URINE SEDIMENT; GLOMERULONEPHRITIS, IGA; INCIDENCE; INFORMATION PROCESSING; METABOLISM; PATIENT SELECTION; TREATMENT OUTCOME;

DATA COLLECTION; GLOMERULONEPHRITIS, IGA; HEMATURIA; HUMANS; INCIDENCE; JAPAN; PATIENT SELECTION; PROTEINURIA; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84903382002     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-013-0849-x     Document Type: Article

References (19)

1. Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases. Am J Kidney Dis. 1997;29:526-32. (Pubitemid 27155272)
2. Pozzi C, Bolasco PG, Fogazzi GB, et al. Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet. 1999;353:883-7. (Pubitemid 29126876)
3. Hotta O, Miyazaki M, Furuta T, et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001;38:736-43.
4. Matsuzaki K, Suzuki Y, Nakata J et al. Nationwide survey on current treatments for IgA nephropathy in Japan. Clin Exp Nephrol. 2013 (epub ahead of print). http://link.springer.com/content/pdf/10.1007%2Fs10157-013-0779-7. Accessed 22 March 2013.
5. Reich HN, Troyanov S, Scholey JW, et al. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol. 2007;18:3177-83. (Pubitemid 350223978)
6. Hwang HS, Kim BS, Shin YS, et al. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria. Nephrology. 2010;15:236-41.
7. Tatematsu M, Yasuda Y, Morita Y, et al. Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy. Clin Exp Nephrol. 2012;16:883-91.
8. Imai E, Horio M, Yamagata K, et al. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res. 2008;31:433-41. (Pubitemid 351597496)
9. Iseki K, Tokashiki K, Iseki C, et al. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63:1468-74. (Pubitemid 36350012)
10. Pozzi C, Andrulli S, Del Vecchio L, et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004;15:157-63. (Pubitemid 38020707)
11. Li PK, Leung CB, Chow KM, et al. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study. Am J Kidney Dis. 2006;47:751-60.
12. Endo M. Epidemiology and prognosis of IgA nephropathy. Nihon Jinzo Gakkai Shi. 2008;50:442-7.
13. Goto M, Wakai K, Kawamura T, et al. A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transpl. 2009;24:3068-74.
14. Szeto CC, Lai FM, To KF, et al. The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria. Am J Med. 2001;110:434-7.
15. Shen P, He L, Li Y, et al. Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients. Nephron Clin Pract. 2007;106(4):c157-61. (Pubitemid 47172275)
16. Scientific Committee, Japanese Society of Nephrology. Evi-dence- based practice guideline for the treatment of CKD. Tokyo:Tokyo Igakusya; 2009.
17. Commitee for Diagnostic Guidelines of Hematuria. Guidelines for diagnosis of hematuria. Nihon Jinzo Gakkai Shi. 2006;48(Suppl):1-34.
18. Committee of revision of clinical practice guidebook 2012 for diagnosis and treatment of CKD. Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012. Tokyo:Tokyo Igakusha; 2012.
19. Japanese Society of Nephrology. Nephrotic syndrome diagnosis guidelines. Nihon Jinzo Gakkai Shi. 2011;53:78-122.